natur
histori
chronic
obstruct
pulmonari
diseas
copd
exacerb
signific
impact
mortal
especi
requir
hospit
admiss
inde
exacerb
becom
frequent
sever
sever
copd
increas
although
exacerb
multipl
caus
infecti
etiolog
far
frequent
figur
hospitaladmit
copd
patient
bacteri
infect
account
onehalf
acut
episod
respiratori
virus
identifi
onequart
rhinoviru
rv
influenza
commonli
detect
viral
pathogen
microbiolog
studi
dovepress
dovepress
gallego
et
al
identifi
chang
sputum
color
purul
good
surrog
marker
bacteri
infect
detect
virus
exacerb
margin
associ
appear
chang
characterist
sputum
respiratori
bacteria
virus
abl
produc
major
local
system
inflammatori
respons
biomark
creactiv
protein
crp
extens
studi
use
altern
test
diagnos
bacteri
infect
copd
pneumonia
likewis
stabl
copd
crp
level
examin
marker
bacteri
colon
andor
subclin
infect
studi
exacerb
copd
patient
includ
viral
etiolog
proven
unabl
distinguish
virusassoci
exacerb
other
fact
recent
studi
clark
et
al
demonstr
higher
level
crp
exacerb
due
virus
posit
cultur
bacteria
studi
evalu
use
crp
predictor
sever
acut
episod
studi
suggest
high
crp
level
marker
exacerb
copd
demonstr
valu
identif
episod
sever
enough
requir
admiss
sever
copd
outpati
studi
crp
scarc
relationship
microorgan
sever
exacerb
fulli
understood
aim
present
studi
identifi
caus
microorgan
either
bacterium
viru
anthonisen
type
iii
exacerb
episod
cohort
sever
copd
outpati
evalu
system
inflammatori
respons
measur
crp
blood
level
assess
impact
sever
episod
measur
need
hospit
admiss
outpati
sever
copd
cohort
regularli
attend
respiratori
diseas
day
care
unit
schedul
exacerb
visit
target
popul
present
studi
patient
includ
cohort
schedul
visit
receiv
educ
selfcar
diseas
person
action
plan
unschedul
visit
exacerb
symptom
appear
describ
elsewher
inclus
criteria
studi
baselin
forc
spirometri
show
forc
expiratori
volum
second
fev
refer
valu
report
three
exacerb
previou
year
age
year
previou
diagnosi
asthma
cystic
fibrosi
cancer
bronchiectasi
diagnos
previou
chest
xray
chronic
treatment
oral
corticosteroid
immunosuppress
drug
longterm
system
inhal
antibiot
therapi
exclus
criteria
studi
ethic
permiss
studi
obtain
sabadel
hospit
ethic
committe
written
inform
consent
given
particip
enrol
baselin
smoke
histori
sever
diseas
bodymass
airflow
obstruct
dyspnea
exercis
index
comorbid
charlson
comorbid
index
use
longterm
home
oxygen
therapi
record
copd
defin
post
bronchodil
ratio
fev
forc
vital
capac
accord
global
initi
chronic
obstruct
lung
diseas
gold
criteria
patient
smoke
habit
packyear
comput
tomographi
scan
obtain
part
patient
baselin
character
order
identifi
undiagnos
bronchiectasi
grade
extens
accord
previous
report
criteria
particip
sever
copd
cohort
underw
schedul
clinic
control
perform
team
pulmonologist
respiratori
daycar
unit
receiv
regular
treatment
longact
betaagonist
anticholinerg
inhal
corticosteroid
accord
current
guidelin
attend
unit
unschedul
visit
acut
symptom
appear
visit
record
togeth
hospit
mortal
due
respiratori
caus
exacerb
suffer
patient
sever
copd
cohort
particip
studi
target
present
studi
episod
requir
unschedul
visit
unit
met
two
anthonisen
criteria
januari
march
consid
studi
episod
acut
symptom
record
togeth
fever
respiratori
rate
rr
upper
respiratori
symptom
nasal
congest
increas
rhinorrhea
sore
throat
chest
xray
perform
rule
pneumonia
blood
analys
includ
blood
count
renal
function
electrolyt
crp
level
arteri
gase
perform
exacerb
spontan
sputum
sampl
obtain
administr
antibiot
decis
regard
treatment
admiss
left
discret
attend
physician
taken
accord
intern
guidelin
exacerb
consid
sever
presenc
criteria
hospit
admiss
episod
prior
antibiot
corticosteroid
administ
day
exclud
final
analysi
intern
journal
copd
submit
manuscript
wwwdovepresscom
creactiv
protein
outpati
copd
exacerb
sputum
sampl
spontan
sputum
sampl
collect
exacerb
process
within
minut
collect
murraywashington
criteria
use
identif
select
sampl
repres
bronchial
secret
sputum
sampl
grade
murray
ivv
cultur
potenti
pathogen
microorgan
ppm
select
media
accord
standard
method
cultur
consid
posit
ppm
recov
briefli
sampl
vortex
second
homogen
sputolysin
solut
obtain
cultur
use
calibr
loop
blood
agar
blood
agar
nalidix
acid
chocol
agar
mcconkey
agar
plate
plate
incub
carbon
dioxid
incub
macconkey
agar
aerob
condit
read
hour
gramneg
gramposit
bacteria
recogn
agent
caus
respiratori
infect
haemophilu
influenza
haemophilu
parainfluenza
streptococcu
pneumonia
moraxella
catarrhali
pseudomona
aeruginosa
staphylococcu
aureu
enterobacteriacea
consid
ppm
number
coloni
form
unit
per
millilit
sputum
calcul
number
coloni
obtain
dilut
sputum
bacteriolog
data
express
total
bacteri
count
log
base
viral
dnarna
extract
respiratori
clinic
sampl
previous
liquefi
sputasol
oxoid
limit
basingstok
uk
water
bath
minut
dnarna
extract
use
qiamp
minelut
viru
spin
procedur
qiacub
qiagen
hilden
germani
obtain
nucleic
acid
elut
multiplex
retrotranscriptasenest
polymeras
chain
reaction
rtpcr
assay
use
simultan
detect
parainfluenza
viru
human
coronaviru
enteroviru
rv
influenza
viru
b
c
respiratori
syncyti
viru
rsv
adenoviru
follow
procedur
describ
coira
et
al
statist
analysi
data
analyz
use
graphpad
prism
version
graphpad
softwar
inc
san
diego
ca
usa
pasw
statist
version
spss
inc
chicago
il
usa
result
categor
variabl
express
absolut
rel
frequenc
continu
variabl
express
mean
valu
standard
deviat
sd
median
interquartil
rang
iqr
distribut
nonnorm
use
gener
estim
equat
gee
logist
model
exchang
withinpati
correl
structur
robust
standard
error
account
individu
patient
multipl
exacerb
gee
logist
regress
model
use
analyz
factor
associ
hospit
admiss
model
includ
patientrel
covari
judg
priori
clinic
relev
pvalu
correl
pair
predictor
examin
ensur
absenc
multicollinear
model
odd
ratio
confid
interv
estim
confid
gee
analys
univari
analysi
carri
first
one
hundr
eighteen
patient
sever
copd
cohort
met
inclus
criteria
studi
studi
popul
predominantli
male
mean
sd
age
total
sputum
sampl
collect
full
microbiolog
analys
possibl
exacerb
provid
sampl
valid
analysi
accord
murraywashington
criteria
harbor
enough
materi
perform
rtpcr
figur
pathogen
bacteria
cultiv
episod
h
influenza
pneumonia
catarrhali
p
aeruginosa
frequent
recov
speci
sampl
virus
detect
rv
common
follow
parainfluenza
influenza
viru
coronaviru
rv
adenoviru
virus
identifi
sampl
neg
cultur
bacteria
exacerb
cultur
show
bacteri
infect
accordingli
consid
coinfect
episod
relationship
bacteri
type
virus
detect
show
statist
signific
season
viru
distribut
demonstr
higher
preval
viru
infect
fall
winter
rv
present
time
year
parainfluenza
influenza
rsv
predomin
isol
fall
winter
figur
tabl
crp
relat
bacteri
load
except
pneumonia
signific
correl
observ
figur
episod
due
pneumonia
also
report
fever
requir
hospit
admiss
frequent
microorgan
respect
selfreport
upper
airway
symptom
similar
across
group
tabl
exacerb
studi
signific
differ
crp
level
found
communityattend
episod
mgl
iqr
hospit
episod
mgl
iqr
marker
exacerb
sever
rr
sao
pao
paco
also
associ
need
hospit
admiss
tabl
increas
crp
significantli
associ
increas
rr
leukocyt
fall
sao
rho
rho
rho
respect
gee
model
assess
influenc
inflammatori
respons
exacerb
sever
crp
emerg
predict
along
longterm
oxygen
therapi
baselin
hypercapnia
adjust
clinic
variabl
comorbid
basal
hypercapnia
crp
remain
model
fourfold
risk
hospit
admiss
crp
level
mgl
tabl
wellcharacter
cohort
sever
copd
patient
anthonisen
type
iii
exacerb
system
inflamm
measur
crp
associ
bacteri
etiolog
mainli
pneumonia
h
influenza
bacteri
load
pneumonia
caus
agent
crp
addit
good
predictor
sever
exacerb
patient
crp
level
mgl
present
fourfold
increas
hospit
basal
hypercapnia
emerg
addit
predictor
admiss
cohort
thu
crp
emerg
good
biolog
marker
identif
sever
exacerb
copd
patient
advanc
diseas
mainli
relat
bacteri
infect
due
pneumonia
h
influenza
preval
infect
sever
copd
outpati
studi
figur
bacteria
virus
onehalf
coinfect
pathogen
bacteria
data
similar
obtain
studi
focus
patient
requir
hospit
due
sever
episod
suggest
etiolog
pattern
character
sever
copd
exacerb
h
influenza
frequent
recov
bacteria
present
studi
caus
onequart
crp
level
peripher
blood
clearli
relat
etiolog
exacerb
studi
popul
highest
figur
pneumonia
h
influenza
statist
signific
relationship
bacteri
load
blood
level
inflammatori
marker
pneumonia
system
impact
ppm
assess
patient
pneumonia
relat
sever
prognosi
determin
hostpathogen
interact
favor
cpolysaccharid
pneumococc
cell
wall
inflammatori
power
h
influenza
bronchial
tree
well
known
relat
microbi
load
system
effect
ppm
studi
margin
present
result
confirm
bronchial
infect
due
h
influenza
clear
system
effect
sever
copd
patient
measur
crp
level
peripher
blood
equival
effect
found
pneumoniaerel
exacerb
find
clinic
signific
h
influenza
preval
caus
exacerb
patient
infect
h
influenza
pneumonia
caus
nearli
onehalf
episod
contrast
viru
detect
associ
lower
crp
level
sever
result
odd
previou
studi
report
higher
level
serum
crp
patient
virusinduc
exacerb
differ
probabl
due
characterist
episod
report
consist
exacerb
appear
followup
cohort
sever
copd
outpati
previou
studi
focus
sever
exacerb
requir
hospit
thu
miss
milder
episod
may
partial
relat
virus
probabl
evolv
lower
crp
level
unfortun
previous
report
crp
level
unabl
predict
etiolog
due
overlap
level
differ
microorgan
studi
crp
level
clearli
relat
need
hospit
crp
mgl
probabl
admiss
rose
fourfold
high
crp
figur
mainli
relat
bacteri
infect
pneumonia
h
influenza
relationship
depend
covari
assess
support
role
inflammatori
marker
manag
exacerb
appear
sever
copd
outpati
howev
previou
studi
prove
valuabl
predict
outcom
studi
suggest
similar
pneumonia
relat
signific
crp
manag
entiti
fact
cutoff
mgl
associ
advers
outcom
demonstr
predict
abil
select
patient
requir
intens
care
unit
icu
admiss
similar
valu
crp
report
copd
exacerb
select
patient
requir
icu
admiss
although
number
patient
includ
small
draw
conclus
studi
also
underlin
import
baselin
hypercapnia
marker
sever
acut
episod
agreement
previou
studi
associ
abnorm
surviv
baselin
hypercapnia
doubl
risk
hospit
admiss
seem
reason
think
identifi
subgroup
frail
patient
least
cohort
two
studi
exacerb
copd
patient
addit
arteri
blood
ga
paramet
oxygen
carbon
dioxid
partial
pressur
ph
improv
predict
mortal
hospit
close
relat
need
admiss
howev
baselin
data
record
studi
present
studi
limit
relat
patient
select
particip
sever
copd
popul
regularli
attend
respiratori
daycar
unit
result
extrapol
copd
popul
whole
number
episod
record
differ
patient
also
vari
wide
even
though
use
gee
approach
overcom
problem
rule
possibl
overrepresent
particular
subset
patient
may
suscept
specif
microorgan
final
infect
uncommon
respiratori
virus
metapneumoviru
bocaviru
evalu
studi
true
preval
viru
infect
may
therefor
slightli
underestim
conclus
studi
demonstr
high
preval
bacteri
infect
mainli
due
h
influenza
pneumonia
catarrhali
p
aeruginosa
exacerb
appear
sever
copd
outpati
preval
viral
infect
significantli
lower
system
inflamm
identifi
crp
blood
level
higher
bacteri
infect
mainli
h
influenza
pneumonia
caus
high
figur
inflammatori
biomark
relat
sever
episod
find
suggest
crp
blood
level
may
use
biomark
manag
exacerb
appear
sever
patient
